Characterizing the impact of renal impairment on the clinical pharmacology of biologics.

Journal of clinical pharmacology

Volumn 52, Issue 1 Suppl, 2012, Pages

  Meibohm, Bernd ^a   Zhou, Honghui ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; PROTEIN;

DRUG LEGISLATION; HUMAN; KIDNEY; KIDNEY FAILURE; METABOLISM; REVIEW;

BIOLOGICAL AGENTS; HUMANS; KIDNEY; LEGISLATION, DRUG; PROTEINS; RENAL INSUFFICIENCY;

MLCS; MLOWN;

EID: 84860324841     PISSN: None     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270011413894     Document Type: Review

References (0)